Graticule Asia Macro Advisors LLC Biocryst Pharmaceuticals Inc Transaction History

Graticule Asia Macro Advisors LLC

  • $0
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $937,860 - $1.16 Million
-66,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$9.5 - $17.24 $323,000 - $586,160
-34,000 Reduced 34.0%
66,000 $1.04 Million
Q1 2021

May 17, 2021
BUY
$7.37 - $13.61 $737,000 - $1.36 Million
100,000 New
100,000 $1.02 Million

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Graticule Asia Macro Advisors LLC Portfolio

Follow Graticule Asia Macro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email